The global Lab-On-A-Chip And Microarrays (biochip) Market was valued at US$ 15,268.0 Mn in 2022 and is forecast to reach a value of US$ 41,690.9 Mn by 2030 at a CAGR of 13.43% between 2023 and 2030. The lab-on-a-chip and microarrays (biochip) market is experiencing strong growth due to the increasing incidence of chronic diseases and rise in demand for point-of-care testing across the world. Moreover, rise in application of proteomics and genomics in cancer research and rise in demand for microfluidics materials is expected to boost the growth of the market. However, factors such as availability of alternative technologies and design constraints of lab-on-chip technology is expected to hamper growth of the market.
Prominent Players in the Lab On A Chip Industry
- Merck KgaA,: The three primary business sectors of Merck KGaA are life sciences, performance materials, and healthcare. Researchers in academia and applied disciplines, such as the biopharmaceutical business, are supplied with laboratory supplies and equipment by the life sciences section. Established in 1891. German headquarters in Darmstadt. A legally binding deal has been struck by Merck to buy the chemical division of Mecaro Co. Ltd. (Mecaro), a publicly traded Korean manufacturer of heater blocks and chemical precursors for semiconductors.
- QIAGEN NV: DNA, RNA, and proteins can be extracted, purified, amplified, and interpreted using Qiagen's unique sample and assay technologies. The company's sales are split roughly evenly between molecular diagnostics and applications in the life sciences. created in 1984. Headquarters in Germany's Hilden. In 2020, Thermo Fisher Scientific purchased QIAGEN N.V.
- PerkinElmer Inc.: Revvity serves the pharmaceutical, biomedical, chemical, environmental, and general industrial markets with tools, tests, services, and software. There are two business segments. The first is that its diagnostics segment covers applied genomics, reproductive health, and immunodiagnostics. Second, it includes applications in the life sciences, industry, the environment, and food in its discovery and analytical solutions. Revvity provides a variety of goods and services, including enterprise software, genetic testing, and instruments for environmental analysis. Established in 1937. Admin centre in the U.S.
- Thermo Fisher Scientific: In order to meet the demands of difficult analytical problems in research, diagnostics, and clinical laboratories, Thermo Fisher Scientific Inc. (Thermo Fisher) offers medical equipment, analytical instruments, reagents and consumables, software, and services. Thermo Fisher Scientific sells reagents for life sciences, laboratory supplies, and equipment for diagnostics. Founded 1956. United States headquarters.
- Fluidigm Corporation: Stephen Quake, Ph. created Fluidigm in 1999 under the name "Mycometrix" with its main office in South San Francisco, California, USA. Fluidigm is a top supplier of crucial equipment and supplies that will fuel future health care discoveries. InstruNor (Feb 2020), DVS Sciences (Jan 2014), and Arcxis Biotechnologies (Unknown Date) are the most recent acquisitions.
- Bio-Rad Laboratories Inc.: With its headquarters in Hercules, California, Bio-Rad Laboratories creates, produces, and sells goods and services for the clinical diagnostics and life sciences industries. Built in 1952. United States headquarters. Recent acquisitions include Celsee Diagnostics (April 2020), PCR|ONE (Aug 2022), and Dropworks.
- Agilent Technologies Inc.: Agilent, which was first separated from Hewlett-Packard in 1999, has grown into a major player in the life sciences and diagnostics industries. With its three operating segments—life science and applied tools, cross lab (containing of consumables and services connected to life science and applied tools), and diagnostics and genomics—Agilent's measuring solutions currently serve a wide range of clients. The most recent acquisitions include Resolution Bioscience (Mar 2021), PSS Polymer Standards Service (Aug 2022), and Avida Biomed (Jan 2023).
- Abbott Laboratories: Abbott produces and sells branded generic pharmaceuticals, adult and paediatric nutritional items, diagnostic tools, and testing kits. Pacemakers, implanted cardioverter defibrillators, neuromodulation tools, coronary stents, catheters, baby formula, adult dietary liquids, molecular diagnostic platforms, immunoassays, and point-of-care diagnostic tools are among the products. Built in 1888. American headquarters in North Chicago. Recent Acquisitions: Cephea Valve Technologies (Jan 2019), JETi (Sep 2021), Cardiovascular Systems (Feb 2023).
- Danaher Corporation (Cepheid): created in Founded 1969. Admin centre in the U.S. The founders of Danaher converted a real estate company into a manufacturing business with an industrial focus in 1984. Danaher today largely concentrates on producing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. This has been achieved through a succession of mergers, acquisitions, and divestitures. The business revealed plans to sell it’s environmental and applied solutions division in 2023, allowing it to only concentrate on the life sciences and diagnostics.
*Definition: A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that allow many tests to be performed at the same time to achieve higher throughput and speed. A biochip can complete thousands of biological reactions
